These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 31285360)

  • 1. Nanotechnology based therapeutics for lung disease.
    Doroudian M; MacLoughlin R; Poynton F; Prina-Mello A; Donnelly SC
    Thorax; 2019 Oct; 74(10):965-976. PubMed ID: 31285360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology and nanomedicine: going small means aiming big.
    Teli MK; Mutalik S; Rajanikant GK
    Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine for the management of lung and blood diseases.
    Buxton DB
    Nanomedicine (Lond); 2009 Apr; 4(3):331-9. PubMed ID: 19331540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
    Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy.
    Verma R; Rao L; Nagpal D; Yadav M; Kumar V; Kumar V; Kumar H; Parashar J; Bansal N; Kumar M; Pandey P; Mittal V; Kaushik D
    Recent Pat Nanotechnol; 2024; 18(4):395-414. PubMed ID: 37537775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for Cystic Fibrosis.
    Ong V; Mei V; Cao L; Lee K; Chung EJ
    SLAS Technol; 2019 Apr; 24(2):169-180. PubMed ID: 30707858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
    Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
    Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine: a new frontier in cancer therapeutics.
    Lee PY; Wong KK
    Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine--prospective therapeutic and diagnostic applications.
    Emerich DF
    Expert Opin Biol Ther; 2005 Jan; 5(1):1-5. PubMed ID: 15709905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
    Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
    Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of reflecting on treatment and post-treatment care when assessing the social aspects of cosmetic nanomedicine and transdermal delivery system.
    Duché G; Thordarson P; Kearnes M
    Nanomedicine; 2020 Aug; 28():102214. PubMed ID: 32360550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases.
    Tian Y; Chen J; Zahtabi F; Keijzer R; Xing M
    Pediatr Pulmonol; 2013 Nov; 48(11):1098-111. PubMed ID: 23997035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second world conference on nanomedicine and drug delivery.
    Ninan N; Thomas S; George A; Sebastian M
    Ther Deliv; 2011 Jun; 2(6):711-5. PubMed ID: 22822503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of core-multishell nanostructured models for nano-biomedical and nano-biopharmaceutical application.
    Šetrajčić-Tomić AJ; Popović JK; Vojnović M; Džambas LD; Šetrajčić JP
    Biomed Mater Eng; 2018; 29(4):451-471. PubMed ID: 30282343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The nanotechnology as a support for diagnosis and prognosis in cancer research].
    Romero-Morelos P; Peralta-Rodríguez R; Mendoza-Rodríguez M; Valdivia-Flores A; Marrero-Rodríguez D; Paniagua-García L; Rodríguez-Cabrales J; Parra-Melquiádez M; Salcedo-Vargas M
    Rev Med Inst Mex Seguro Soc; 2011; 49(6):621-30. PubMed ID: 22176824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoinformatics and DNA-based computing: catalyzing nanomedicine.
    Maojo V; Martin-Sanchez F; Kulikowski C; Rodriguez-Paton A; Fritts M
    Pediatr Res; 2010 May; 67(5):481-9. PubMed ID: 20118825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.